The association of glycemic control and AST:ALT ratio in type 2 diabetes mellitus of younger and older patients
Project Description
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Duration
2025 - Ongoing
Project Lead
Jinkala Shamsheer
Authors
Jinkala Shamsheer , Dr. Vinod George Thukkadavil, Mrs. Anu Maliyakal
Project Status
ongoing
Project Type
Student Project